UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine

Cancer research (Chicago, Ill.), 2010-01, Vol.70 (1), p.68-77

2010

Volltextzugriff (PDF)

Myeloid suppressor cell depletion augments antitumor activity in lung cancer

PloS one, 2012-07, Vol.7 (7), p.e40677

2012

Volltextzugriff (PDF)

From diagnostic testing to precision medicine: the evolving role of genomics in cardiac channelopathies and cardiomyopathies in children

Current opinion in genetics & development, 2022-10, Vol.76, p.101978-101978, Article 101978

2022

Volltextzugriff (PDF)

Drain Current Modeling of Tunnel FET using Simpson’s Rule

SILICON, 2022-07, Vol.14 (11), p.5931-5939

2022

Volltextzugriff (PDF)

Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (21), p.4517-4526

2015

Volltextzugriff (PDF)

Isolation and purification of lignin and silica from the black liquor generated during the production of bioethanol from rice straw

Biomass & bioenergy, 2012-04, Vol.39, p.210-217

2012

Volltextzugriff (PDF)

APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application

Cancer Immunology, Immunotherapy, 2021-07, Vol.70 (7), p.1853-1865

2021

Volltextzugriff (PDF)

Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth

PloS one, 2011-05, Vol.6 (5), p.e18758

2011

Volltextzugriff (PDF)

Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade

Cancer cell, 2024-03, Vol.42 (3), p.429-443.e4

2024

Volltextzugriff (PDF)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2023-11, Vol.29 (22), p.4596-4605

2023

Volltextzugriff (PDF)

Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

Journal of neuroinflammation, 2012-05, Vol.9 (1), p.99-99, Article 99

2012

Volltextzugriff (PDF)

IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

Journal of experimental & clinical cancer research, 2013-11, Vol.32 (1), p.97-97, Article 97

2013

Volltextzugriff (PDF)

Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL

Scientific reports, 2017-08, Vol.7 (1), p.9192-13, Article 9192

2017

Volltextzugriff (PDF)

Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial

Journal for immunotherapy of cancer, 2023-10, Vol.11 (10), p.e007047

2023

Volltextzugriff (PDF)

Response- and Progression-Based End Points in Trial and Observational Cohorts of Patients With NSCLC

JAMA network open, 2024-05, Vol.7 (5), p.e249286-e249286

2024

Volltextzugriff (PDF)

527 Clonal hematopoiesis is associated with reduced response to immune checkpoint inhibitors in lung cancer

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A598-A599

2023

Volltextzugriff (PDF)

Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80

The Journal of immunology (1950), 2011-06, Vol.186 (12), p.6822-6829

2011

Volltextzugriff (PDF)

Myeloid suppressor cells and immune modulation in lung cancer

Immunotherapy, 2012-03, Vol.4 (3), p.291-304

2012

Volltextzugriff (PDF)

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer

Oncoimmunology, 2012-12, Vol.1 (9), p.1650-1651

2012

Volltextzugriff (PDF)

Abstract 3215: GITRL-Fc can significantly reduce tumor growth by stimulating innate and adaptive immunity

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3215-3215

2016

Volltextzugriff (PDF)

Abstract 2214: GITR ligand fusion protein (GITRL-Fc) induces T cell mediated anti-tumor immune response and can combine with anti-PDL1 to enhance anti-tumor immunity and long-term immune memory

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2214-2214

2016

Volltextzugriff (PDF)

Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

Cancer Immunology, Immunotherapy, 2008-10, Vol.57 (10), p.1493-1504

2008

Volltextzugriff (PDF)

Role of CXCR3 Ligands in IL-7/IL-7Rα-Fc―Mediated Antitumor Activity in Lung Cancer

Clinical cancer research, 2011-06, Vol.17 (11), p.3660-3672

2011

Volltextzugriff (PDF)

Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis

Oncoimmunology, 2016-05, Vol.5 (5), p.e1120399-e1120399

2016

Volltextzugriff (PDF)

601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A684-A684

2023

Volltextzugriff (PDF)

1 – 25 von 370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(264)
Mit Volltextzugriff
(296)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(364)
Japanisch
(4)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine

Myeloid suppressor cell depletion augments antitumor activity in lung cancer

From diagnostic testing to precision medicine: the evolving role of genomics in cardiac channelopathies and cardiomyopathies in children

Drain Current Modeling of Tunnel FET using Simpson’s Rule

Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells

Isolation and purification of lignin and silica from the black liquor generated during the production of bioethanol from rice straw

APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application

Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth

Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer

Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL

Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial

Response- and Progression-Based End Points in Trial and Observational Cohorts of Patients With NSCLC

527 Clonal hematopoiesis is associated with reduced response to immune checkpoint inhibitors in lung cancer

Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80

Myeloid suppressor cells and immune modulation in lung cancer

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer

Abstract 3215: GITRL-Fc can significantly reduce tumor growth by stimulating innate and adaptive immunity

Abstract 2214: GITR ligand fusion protein (GITRL-Fc) induces T cell mediated anti-tumor immune response and can combine with anti-PDL1 to enhance anti-tumor immunity and long-term immune memory

Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

Role of CXCR3 Ligands in IL-7/IL-7Rα-Fc―Mediated Antitumor Activity in Lung Cancer

Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis

601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC

Suchergebnisse filtern